Human Papillomavirus Clinical Trials

89 clinical trials for Human Papillomavirus across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune) — RECRUITING
• Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV) — RECRUITING
• The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Health Beliefs, and Vaccination Behavior Intentions — RECRUITING · NA
• The Role of Circulating Tumour DNA in Head and Neck Cancer — RECRUITING
• Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer — RECRUITING · NA
• Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) — RECRUITING · PHASE4
• Primary HPV Self-Collection in Indonesia — RECRUITING · NA
• Provider Recommendation and HPV Vaccination — RECRUITING · NA
• Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP) — NOT_YET_RECRUITING · PHASE2
• Effect of HPV Education on Women's Knowledge — COMPLETED · NA
• A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers — ACTIVE_NOT_RECRUITING · PHASE1
• C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States — NOT_YET_RECRUITING
• Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya — COMPLETED · PHASE2
• Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV — NOT_YET_RECRUITING · NA
• Knowledge of 18-19 Years Old About Papillomavirus and HPV Vaccination — COMPLETED
• Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV — COMPLETED · NA
• Comparisons of the Effects and Clinical Outcomes of CH2 Vaginal Gel Versus Placebo on CIN1 — ACTIVE_NOT_RECRUITING · NA
• Interactive, Health Literacy Promoting Text Messages and HPV Vaccine Completion In Minority Adolescents — COMPLETED · NA
• Perception, Awareness, and Acceptance of Human Papillomavirus Disease and Vaccine Among Parents of Boys Aged 9 to 18 Years — COMPLETED
• Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology — OTHER · NA
• Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening — COMPLETED
• Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3) — COMPLETED · PHASE2
• Longitudinal HPV Pap in CIN and VAIN — OTHER
• Predictors of CIN Study Series 5.0:Stability Study in Vaginal Self-samples — COMPLETED · NA
• Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females — COMPLETED · PHASE2
• Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females — COMPLETED · PHASE2
• Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections — OTHER · NA
• Natural History of HPV Infection in Men: The HIM Study — COMPLETED
• Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3 — COMPLETED · NA
• Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2) — COMPLETED
• RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC — WITHDRAWN · PHASE2
• The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men — TERMINATED · NA
• Comparing Strategies for Implementing Primary HPV Screening — OTHER · NA
• Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention — COMPLETED · NA
• Study of Gardasil in Mid-Adult Males (MAM) — COMPLETED · PHASE2
• Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine — COMPLETED · PHASE4
• Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions — TERMINATED · PHASE1
• Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens — COMPLETED
• Normalizing HPV Vaccination in Preteens With a Serious Video Game — COMPLETED · NA
• txt2protect: Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men — COMPLETED · NA
• Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics — COMPLETED · NA
• Evaluation of Immune Response Against Human Papillomavirus (HPV)in Patients With Metastatic Cancer of the Anal Canal — COMPLETED · NA
• Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination — COMPLETED
• Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later. — COMPLETED · PHASE3
• Study of the Prevention of Anal Cancer — COMPLETED · NA
• New Strategies to Assess Anal Cancer Risk In Women — COMPLETED
• A Cohort Study to Assess Sustained Immunogenicity to qHPV Vaccine Among HIV-infected Girls and Boys Age 9-14 Years — COMPLETED
• Immunogenicity and Tolerability of V503 Versus GARDASIL (V503-009) — COMPLETED · PHASE3
• HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma — OTHER
• Safety and Tolerability of GX-I7 in HPV-infected Female Volunteers — COMPLETED · PHASE1

Refine this search